95 related articles for article (PubMed ID: 10560497)
41. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
[TBL] [Abstract][Full Text] [Related]
42. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].
Jeanfaivre T; Chassevent A; Larra F; Tuchais E
Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603
[TBL] [Abstract][Full Text] [Related]
43. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
44. Allelic imbalance at the 5q14 locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs). Possible synergistic effect with p53 gene alterations on apoptosis.
Gorgoulis VG; Mariatos1 G; Manolis EN; Zacharatos P; Kotsinas A; Liloglou T; Vogiatzi T; Tsagkaraki A; Kokotas S; Tsoli E; Alchanatis M; Sfikakis PP; Asimacopoulos PJ; Field JK; Kittas C
Lung Cancer; 2000 Jun; 28(3):211-24. PubMed ID: 10812190
[TBL] [Abstract][Full Text] [Related]
45. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
46. Correlation between angiogenesis, apoptosis and cell proliferation in invasive ductal carcinoma of the breast and their relation to tumor behavior.
Lee JS; Kim HS; Jung JJ; Kim YB; Park CS; Lee MC
Anal Quant Cytol Histol; 2001 Apr; 23(2):161-8. PubMed ID: 11332083
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of chromosomal imbalances in squamous cell carcinoma and adenocarcinoma of the lung.
Danner BC; Hellms T; Jung K; Gunawan B; Didilis V; Füzesi L; Schöndube FA
Ann Thorac Surg; 2011 Sep; 92(3):1038-43. PubMed ID: 21871296
[TBL] [Abstract][Full Text] [Related]
48. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
[TBL] [Abstract][Full Text] [Related]
49. Imbalance of cell proliferation and apoptosis during progression of lung carcinomas.
Mattern J; Volm M
Anticancer Res; 2004; 24(6):4243-6. PubMed ID: 15736479
[TBL] [Abstract][Full Text] [Related]
50. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
51. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
[TBL] [Abstract][Full Text] [Related]
52. Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer.
Oyama T; Mitsudomi T; Mizoue T; Ohgami A; Osaki T; Nakanishi R; Yasumoto K
Surg Oncol; 1995; 4(2):83-9. PubMed ID: 7551263
[TBL] [Abstract][Full Text] [Related]
53. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases.
Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
Cancer; 1999 Oct; 86(7):1174-81. PubMed ID: 10506701
[TBL] [Abstract][Full Text] [Related]
54. Predicting lung cancer prognosis using machine learning.
Burki TK
Lancet Oncol; 2016 Oct; 17(10):e421. PubMed ID: 27569440
[No Abstract] [Full Text] [Related]
55. Balance between cell division and cell death as predictor of survival in patients with non-small-cell lung cancer.
Puglisi F; Minisini AM; Aprile G; Barbone F; Cataldi P; Artico D; Damante G; Beltrami CA; Di Loreto C
Oncology; 2002; 63(1):76-83. PubMed ID: 12187075
[TBL] [Abstract][Full Text] [Related]
56. A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labeling.
Yoshida K; Morinaga S; Shimosato Y; Hayata Y
Cancer; 1989 Dec; 64(11):2284-91. PubMed ID: 2553243
[TBL] [Abstract][Full Text] [Related]
57. [Analysis of proliferating cell nuclear antigen (PCNA) expression in 24 cases of primary non-small cell pulmonary carcinomas and correlation with survival].
Castellano VM; Sotelo T; Ballestín C; López-Encuentra A; Varela G
Arch Bronconeumol; 1996 Mar; 32(3):127-31. PubMed ID: 8634790
[TBL] [Abstract][Full Text] [Related]
58. Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells.
Lee TK; Horner RD; Silverman JF; Chen YH; Jenny C; Scarantino CW
Cancer; 1989 Jan; 63(2):309-16. PubMed ID: 2535956
[TBL] [Abstract][Full Text] [Related]
59. Characteristics of long-term survivors of untreated lung cancer.
Mattern J; Koomägi R; Volm M
Lung Cancer; 2002 Jun; 36(3):277-82. PubMed ID: 12009238
[TBL] [Abstract][Full Text] [Related]
60. [Study of the expression of proliferating cell nuclear antigen and p185 in non-small cell lung carcinoma].
Alemany Monraval P; Martorell Cebollada M; Salvador Villalba I; Martínez Leandro E
Arch Bronconeumol; 1996 Apr; 32(4):165-9. PubMed ID: 8689012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
